PRETAGOSTINI, Renzo
 Distribuzione geografica
Continente #
NA - Nord America 5.966
EU - Europa 1.904
AS - Asia 964
AF - Africa 61
SA - Sud America 58
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.960
Nazione #
US - Stati Uniti d'America 5.890
IT - Italia 579
IN - India 389
SE - Svezia 380
UA - Ucraina 307
SG - Singapore 286
FI - Finlandia 260
CN - Cina 251
DE - Germania 141
BG - Bulgaria 89
CA - Canada 65
AR - Argentina 56
TG - Togo 49
IE - Irlanda 43
GB - Regno Unito 38
IR - Iran 27
RO - Romania 13
BE - Belgio 10
FR - Francia 8
MX - Messico 8
AT - Austria 7
CH - Svizzera 7
NL - Olanda 6
BJ - Benin 5
TR - Turchia 4
ZA - Sudafrica 4
AU - Australia 3
BZ - Belize 3
ES - Italia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PL - Polonia 3
TW - Taiwan 3
DK - Danimarca 2
GR - Grecia 2
BD - Bangladesh 1
BO - Bolivia 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
MA - Marocco 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 8.960
Città #
Fairfield 849
Chandler 538
Woodbridge 498
Ashburn 407
Seattle 320
Houston 318
Cambridge 279
Wilmington 278
Ann Arbor 268
Princeton 268
Plano 202
Rome 180
Dearborn 144
Singapore 134
Beijing 131
Jacksonville 124
Boston 98
Millbury 97
Lawrence 90
Sofia 89
San Paolo di Civitate 86
San Diego 80
Andover 66
Helsinki 66
Bremen 53
Federal 53
Lomé 49
Dublin 43
Des Moines 38
Boardman 34
Norwalk 34
Ottawa 33
Toronto 27
Grafing 26
Falls Church 22
Milan 21
New York 19
Kunming 18
Nanjing 16
Bühl 15
Hefei 15
Zanjan 15
Los Angeles 13
San Mateo 11
Brussels 10
Mannheim 10
Buffalo 9
Jinan 9
Leawood 9
San Jose 8
Mexico City 7
Regensburg 7
Vienna 7
Arzergrande 6
Frankfurt am Main 6
Guangzhou 6
Indiana 6
Laurel 6
Nanchang 6
Redmond 6
Fasano 5
Pescara 5
Sacramento 5
Shanghai 5
Washington 5
Azzano San Paolo 4
Chengdu 4
Dallas 4
Fremont 4
Henderson 4
Istanbul 4
London 4
Panicale 4
Pisa 4
Southend 4
Atlanta 3
Auburn Hills 3
Auckland 3
Augusta 3
Basiano 3
Belize City 3
Bern 3
Bologna 3
Buenos Aires 3
Fucecchio 3
Jerzu 3
Jian 3
Kumanovo 3
Montréal 3
Mumbai 3
Pontinia 3
Rieti 3
Shenyang 3
Torino 3
Trumbull 3
Vicopisano 3
Warsaw 3
Wuhan 3
Bolzano Vicentino 2
Caserta 2
Totale 6.421
Nome #
CELSIOR: UNA NUOVA SOLUZIONE EXTRACELLULARE PER LA PERFUSIONE E LA CONSERVAZIONE IPOTERMICA DEGLI ORGANI SOTTODIAFRAMMATICI. ESPERIENZA PERSONALE 243
Delayed introduction of everolimus in de novo renal transplanted patients. A single-center experience 121
Automated intelligent microscopy for the recognition of decoy cells in urine samples of kidney transplant patients 104
Viremia negativization after BK virus infection in kidney transplantation. A national bicentric study 96
Risk Management Systems for Health Care and Safety Development on Transplantation: A Review and a Proposal 93
Clinical Results of Treatment of Postsurgical Endotoxin-Mediated Sepsis With Polymyxin-B Direct Hemoperfusion 89
Delayed Graft Function Decreases Early and Intermediate Graft Outcomes After Expanded Criteria Donor Kidney Transplants 88
Plasmapheresis, photopheresis, and endovenous immunoglobulin in acute antibody-mediated rejection in kidney transplantation 86
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 85
Early Urine Output Predicts Graft Survival After Kidney Transplantation 83
Multiple organ failure associated with Coxsackie virus in a kidney transplant patient. Case report 81
Adacolumn Treatment in Kidney Transplant Patients With Hepatitis C Virus 80
Perfusion time anuria and nephrotoxicity in cadaveric renal transplant. 79
Color Doppler ultrasound in renal transplant: Role of resistive index versus renal cortical ratio in the evaluation of renal transplant diseases 78
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS 78
Allospecific human T suppressor cells in kidney transplantation. 77
EFFICIENCY OF TRANSGENESIS USING SPERM-MEDIATED GENE TRANSFER :GENERATION OF hDAF TRANSGENIC PIGS 77
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 77
Survival after kidney transplantation does not differ with 50-59- or over 60-year-old expanded-criteria donors. 75
Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations. 72
MOFETIL MYCOPHENOLATE IN RENAL TRANSPLANTATION 72
The organizational model of the Interregional Transplant Agency Organizzazione Centro-Sud Trapianti 72
One hundred sixteen cases of acute liver failure treated with MARS 72
Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation 71
A case of portal vein arterialization after a liver transplant 70
Evaluation of suitability of kidney for transplant. Histomorphometric analysis 70
Organizzazione Centro-Sud Trapianti: Outcome analysis 1999 to 2002 70
Alloantibodies and outcomes of deceased donor kidney allografts 69
Pre-emptive therapy for the treatment of cytomegalovirus after kidney transplantation 69
Exchange of organs and patients with foreign nations during the first 15 months of activity of the Italian gate to Europe 68
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS 68
IMMUNOSUPPRESSIVE THERAPY IN HIGH RISK PATIENTS 68
ANALYSIS OF 160 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS: 1983-1997. 67
Transplantation activity in the Organizzazione Centro-Sud Trapianti: A retrospective study from 1999 to March 2004 66
Surgical technique notes of arterial vascular reconstruction during kidney transplantation: personal experience and literature review 66
Intractable pruritus in patients with hepatitis C virus 66
KIDNEY TRANSPLANTATION FROM LIVING DONORS WITH MULTIPLE RENAL ARTERIES. EXPERIENCES WITH FIBRIN SEALING 65
Liver transplantation: expanding the donor pool 65
Opsonic activity of intravenous immunoglobulins used for prophylaxis of infections in transplanted recipients 64
A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. 63
Tacrolimus Trough Levels and Level-to-Dose Ratio in Stable Renal Transplant Patients Converted to a Once-Daily Regimen 63
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS : 8 YEARS GRAFT AND PATIENT SURVIVAL 62
Incidence of neoplastic donors in Organizzazione Centro Sud Trapianti area during the 2003-2005 period. 60
Effect of HLA compatibility, pregnancies, blood transfusions, and taboo mismatches in living unrelated kidney transplantation 60
CLINICAL EXPERIENCE WITH CYCLOSPORIN AT THE ROME UNIVERSITY HOSPITAL. 59
RENAL TRANSPLANTATION FROM LIVING UNRELATED VS. RELATED KIDNEY DONORS 59
SURVIVAL IN KIDNEY TRANSPLANTATION FROM LIVING DONORS: A SINGLE CENTER EXPERIENCE 59
Simultaneous Pancreas-Kidney Transplantation: A Single-Center Experience and Prospective Analysis. 59
CONVERSION FROM CYCLOSPORIN TO TACROLIMUS IN CRHONIC ALLOGRAFT NEPHROPATY 58
Predictive Characteristics of Delayed Graft Function After Expanded and Standard Criteria Donor Kidney Transplantations 58
Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells 58
UNUSUAL CORRELATION OF LATE IGA-NEPHROPATHY RECURRENCE AND RENAL PAPILLARY CARCINOMA DEVELOPED IN A KIDNEY TRANSPLANT RECIPIENT 57
Quality evaluation of solid organ transplant in Italy for the period 2000 to 2002 data from the National Transplant Center 56
ETHICAL CONSIDERATIONS ON KIDNEY TRANSPLANTATION FROM LIVING DONORS 56
94 CONSECUTIVE LIVING UNRELATED KIDNEY TRANSPLANTS: 8 YEARS GRAFT AND PATIENT ACTUARIAL SURVIVAL 55
Renal papillary carcinoma developed in a kidney transplant recipient with late IgA-nephropathy 55
Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival 55
ORGAN ALLOGRAFT RECIPIENTS DEVELOP HLA CLASS I-SPECIFIC T SUPPRESSOR CELLS 55
Pediatric renal transplantation: anesthesia and perioperative complications 55
APHERESIS IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS OF NATIVE AND TRANSPLANTED KIDNEYS: A THERAPEUTIC PROTOCOL. 55
Torque teno virus (TTV): A gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients 54
Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. 54
Reduction of immunosoppressive therapy in kidney and liver transplant patients with T suppressor cells activity 53
MARS (Molecular Adsorbent Recirculating System): experience in 34 cases of acute liver failure 53
Diagnostic value of presepsin for bacterial infection in cirrhosis: a pilot study 53
EVOLUZIONE DELL'IMMUNOSOPPRESSIONE NEL TRAPIANTO CLINICO DI RENE:ESPERIENZA SU 700 CASI 52
null 52
Preharvest Donor Arterial Hyperoxia Protects From Initial Poor Graft Function After Liver Transplantation By Increasing Total Protein Liver Concentration 52
LIVING UNRELATED KIDNEY TRANSPLANTATION DONOR: A VALID AND SAFE SOURCE 51
null 51
The use of neoplastic donors to increase the donor pool 50
Pediatric renal transplantation: Personal experience 50
Monocyte cytotoxic activity in kidney transplant patients 49
ALPHA-INTERFERON THERAPY IN PATIENTS WITH HEPATITIS INFECTION UNDERGOING ORGAN-TRANSPLANTATION 49
Kidney diseases 49
[Pulmonary aspergillosis in patients having undergone a kidney transplant]. 49
Optimization of Mars Treatments in Patients With Aochf 48
Living organ donation, a therapeutic possibility, is still poorly used in Italy: a national analysis. 48
Optimization of the Length of Individual Mars Treatment in Patients With Aochf 48
ORGAN ALLOGRAFT RECIPIENTS DEVELOP HLA-CLASS I SPECIFIC T SUPPRESSOR CELLS 48
Multimodal Therapy with Combined Plasmapheresis, Photoapheresis, and Intravenous Immunoglobulin for Acute Antibody-Mediated Renal Transplant Rejection: A 2-Year Follow-up 48
Strategies to increase heart transplantation in centre-sud transplant organization. 47
Management of hepatitis C virus infection in liver transplantation with adacolumn apheresis 47
Alpha Interferon Therapy in patients with virus hepatitis infection undergoing organ transplantation. 46
Aspiration cytology as a clinical tool for the diagnosis of Cyclosporine induced nephrotoxicity. 45
LA RICOSTRUZIONE ARTERIOSA NEL TRAPIANTO DI FEGATO:NOTE DI TECNICA CHIRURGICA 44
Cadaveric organ donors and malignancy. Our experience in Italy 43
Research for optimization in organ donation in a macro-area after federal reform of the Italian health system 43
Epidemiological study on the infections due to pathogenous microrganisms in an intensive care unit 43
Expected and observed glomerular filtration rates in kidney transplant patients converted to once daily tacrolimus: 10 years of follow-up 43
INFLUENCE OF TOTAL LYMPHOID IRRADIATION PLUS CYCLOSPORINE ON KIDNEY GRAFT OUTCOME IN HIGH-RISK PATIENTS 43
ASPETTI ORGANIZZATIVI E STATO ATTUALE DEL TRAPIANTO DI RENE IN ITALIA 42
BENCH SURGERY FOR MULTIPLE RENAL ARTERIES IN KIDNEY TRANSPLANTATION FROM LIVING DONOR 42
Living kidney transplantation between spouses: results in 100 cases. 42
TRATTAMENTO DELLE NEOPLASIE MALIGNE DEL RENE CON TROMBOSI CAVALE: DESCRIZIONE DI APPROCCIO CHIRURGICO ORIGINALE. 42
Tacrolimus as cornerstone immunosuppressant in kidney transplantation 42
SARS-CoV-2 vaccination with bnt162b2 in renal transplant patients. Risk factors for impaired response and immunological implications 42
RESULTS WITH DONOR KIDNEYS PRESERVED LONGER THAN 4O HOURS 41
Terapia con alpha Interferon nel trapianto d’organo: studio delle attività citotossiche. 41
Italy-Greece cooperation for transplantation of medically urgent Greek patients: Is it an effective, efficient model? 41
Totale 6.257
Categoria #
all - tutte 23.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.953 297 44 20 100 156 325 262 240 185 166 108 50
2020/2021783 109 82 41 124 19 40 27 74 77 116 49 25
2021/20221.923 5 119 156 71 260 38 31 182 149 165 306 441
2022/20231.982 497 345 126 231 207 199 19 94 176 27 43 18
2023/2024924 69 89 21 104 56 134 37 65 7 121 110 111
2024/202546 46 0 0 0 0 0 0 0 0 0 0 0
Totale 9.278